Relaxin signalling in THP-1 cells uses a novel phosphotyrosine-dependent pathway

Molecular and Cellular Endocrinology

Volumn 272, Issue 1-2, 2007, Pages 1-13

  Anand Ivell, Ravinder ^a   Heng, Kee ^a   Bartsch, Olaf ^b   Ivell, Richard ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Adenylate cyclase; LGR7; Protein kinase A; Relaxin; Tyrphostin

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; RELAXIN;

ARTICLE; CELL LINE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MEMBRANE PROTEINS; ORGAN SPECIFICITY; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN KINASE INHIBITORS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 34250174577     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.04.001     Document Type: Article

References (34)

1. Bani D., Failli P., Bello M.G., Thiemermann C., Bani Sacchi T., Bigazzi M., and Masini E. Relaxin activates the l-arginine-nitric oxide pathway in vascular smooth muscle cells in culture. Hypertension 31 (1998) 1240-1247
2. Bartsch O., Bartlick B., and Ivell R. Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol. Hum. Reprod. 7 (2001) 799-809
3. Bartsch O., Bartlick B., and Ivell R. Relaxin signal transduction couples tyrosine phosphorylation to cAMP upregulation. In: Tregear G.W., Ivell R., Bathgate R.A.D., and Wade J.D. (Eds). Relaxin 2000: Proceedings of the 3rd International Conference on Relaxin & Related Peptides (2001), Kluwer Academic Publishers, Dordrecht, the Netherlands 309-316
4. Bartsch O., Bartlick B., and Ivell R. Phosphodiesterase 4 inhibition synergizes with relaxin signalling to promote decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 89 (2004) 324-334
5. Bathgate R.A., Hsueh A.J., Ivell R., Sanborn B.M., Sherwood O.D., and Summers R.J. International Union of Pharmacology. Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 58 (2006) 7-31
6. Dodge K.L., and Sanborn B.M. Evidence for inhibition by protein kinase A of receptor/G alpha(q)/phospholipase C (PLC) coupling by a mechanism not involving PLCbeta2. Endocrinology 139 (1998) 2265-2271
7. Dschietzig T., Bartsch C., Stangl V., Baumann G., and Stangl K. Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J. 18 (2004) 1536-1538
8. Fei D.T., Gross M.C., Lofgren J.L., Mora-Worms M., and Chen A.B. Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells-a specific and high throughput in vitro bioassay. Biochem. Biophys. Res. Commun. 170 (1990) 214-222
9. Figueiredo K.A., Mui A.L., Nelson C.C., and Cox M.E. Relaxin stimulates leukocyte adhesion and migration through a relaxin receptor LGR7-dependent mechanism. J. Biol. Chem. 281 (2006) 3030-3039
10. Halls M.L., Bathgate R.A., and Summers R.J. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol. Pharmacol. 70 (2006) 214-226
11. He H., Hirokawa Y., Gazit A., Yamashita Y., Mano H., Kawakami Y., Hsieh C.Y., Kung H.J., Lessene G., Baell J., Levitzki A., and Maruta H. The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformation. Cancer Biol. Ther. 3 (2004) 96-101
12. Hsu S.Y., Kudo M., Chen T., Nakabayashi K., Bhalla A., van der Spek P.J., van Duin M., and Hsueh A.J. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol. Endocrinol. 14 (2000) 1257-1271
13. Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Sherwood O.D., and Hsueh A.J. Activation of orphan receptors by the hormone relaxin. Science 295 (2002) 671-674
14. Ivell R., Balvers M., Pohnke Y., Telgmann R., Bartsch O., Milde-Langosch K., Bamberger A.M., and Einspanier A. Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod. Biol. Endocrinol. 1 (2003) 114
15. Ivell, R., Heng, K., Anand-Ivell, R., 2007. Diverse signalling mechanisms used by relaxin in natural cells and tissues-the evolution of a "neohormone". In: Agoulnik, A. (Ed.), Relaxin and Related Peptides in Reproduction, Tissue Remodeling and Cancer. Bioscience Publishing, Georgetown, TX (online at http://eurekah.com/chapter/3322).
16. Jaleel M., Shenoy A.R., and Visweswariah S.S. Tyrphostins are inhibitors of guanylyl and adenylyl cyclases. Biochemistry 43 (2004) 8247-8255
17. Jeyabalan A., Novak J., Danielson L.A., Kerchner L.J., Opett S.L., and Conrad K.P. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ. Res. 93 (2003) 1249-1257
18. Kalbag S.S., Roginsky M.S., Jelveh Z., and Sulimovici S. Phorbol ester, prolactin, and relaxin cause translocation of protein kinase C from cytosol to membranes in human endometrial cells. Biochim. Biophys. Acta 1094 (1991) 85-91
19. Kawabe J., Iwami G., Ebina T., Ohno S., Katada T., Ueda Y., Homcy C.J., and Ishikawa Y. Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269 (1994) 16554-16558
20. Kerchner K.R., Clay R.L., McCleery G., Watson N., McIntire W.E., Myu C.S., and Garrison J.C. Diferential sensitivity of phosphatidylinositol 3-kinase p110gamma to isoforms of G protein betagamma dimers. J. Biol. Chem. 279 (2004) 44554-44562
21. Kompa A.R., Samuel C.S., and Summers R.J. Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin. Br. J. Pharmacol. 137 (2002) 710-718
22. Larsson L.I. Novel actions of tyrphostin AG879: inhibition of RAF-1 and HER-2 expression combined with strong antitumoral effects on breast cancer cells. Cell. Mol. Life Sci. 61 (2004) 2624-2631
23. Liu C., Chen J., Sutton S., Roland B., Kuei C., Farmer N., Sillard R., and Lovenberg T.W. Identification of relaxin-3/INSL7 as a ligand for GPCR142. J. Biol. Chem. 278 (2003) 50765-50770
24. Liu C., Eriste E., Sutton S., Chen J., Roland B., Kuei C., Farmer N., Jornvall H., Sillard R., and Lovenberg T.W. Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J. Biol. Chem. 278 (2003) 50754-50764
25. Mayerhofer A., Engling R., Stecher B., Ecker A., Sterzik K., and Gratzl M. Relaxin triggers calcium transients in human granulosa-lutein cells. Eur. J. Endocrinol. 132 (1995) 507-513
26. Mehats C., Tanguy G., Dallot E., Robert B., Rebourcet R., Ferre F., and Leroy M.J. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology 140 (1999) 3228-3237
27. Nguyen B.T., and Dessauer C.W. Relaxin stimulates protein kinase C zeta translocation: requirement for cyclic adenosine 3′,5′-monophosphate production. Mol. Endocrinol. 19 (2005) 1012-1023
28. Nguyen B.T., Yang L., Sanborn B.M., and Dessauer C.W. Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3′,5′-monophosphate by relaxin. Mol. Endocrinol. 17 (2003) 1075-1084
29. Palejwala S., Stein D.E., Weiss G., Monia B.P., Tortoriello D., and Goldsmith L.T. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 142 (2001) 3405-3413
30. Parsell D.A., Mak J.Y., Amento E.P., and Unemori E.N. Relaxin binds to and elicits a response from cells of the human monocyte cell-line, THP-1. J. Biol. Chem. 271 (1996) 27936-27941
31. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402 (1999) 884-888
32. Sanborn B.M., Kuo H.S., Weisbrodt N.W., and Sherwood O.D. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 106 (1980) 1210-1215
33. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
34. Zhang Q., Liu S.H., Erikson M., Lewis M., and Unemori E. Relaxin activates the MAP kinase pathway in human endometrial stromal cells. J. Cell. Biochem. 85 (2002) 536-544